AVADEL PHARMACEUTICALS PLC (NASDAQ:AVDL) Files An 8-K Regulation FD Disclosure
Item 7.01.
The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
(d) Exhibits
| 99.1 | Corporate presentation of Avadel Pharmaceuticals plc, dated December 5, 2019. |
AVADEL PHARMACEUTICALS PLC Exhibit
EX-99.1 2 tm1924482d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Piper – Jaffray Healthcare Conference December 2019 1 Avadel Pharmaceuticals plc Repositioned: Executing New Strategy Safe Harbor This presentation may include forward – looking statements within the meaning of Section 27 A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934 . The words “will,…
To view the full exhibit click here